(Source: Business Wire)King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a live webcast of its presentation scheduled for Tuesday, September 22, 2009, at 11:00 a.m. ET, at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York, New York. The presentation may include a discussion of the Company's marketed products, pipeline, strategy for growth, financial results and expectations, and other matters relating to its business. Interested persons may access the live webcast via the internet on the King Pharmaceuticals website at http://www.kingpharm.com/webcasts/. A replay of the webcast may be accessed at this same link for a period of not less than 14 days after the live event.

About King Pharmaceuticals, Inc.

King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital. King's wholly-owned subsidiary, Alpharma, Inc., is also a leader in the development, registration, manufacture and marketing of pharmaceutical products for food producing animals.

Forward-looking Statements

This release contains forward-looking statements which reflect management's current views of future events and operations, including, but not limited to, statements pertaining to the anticipated webcast of the Company's presentation on September 22, 2009. These forward-looking statements involve certain significant risks and uncertainties, and actual results may differ materially from the forward-looking statements. An important factor which may cause results to differ is whether King is able to webcast the presentation on September 22, 2009 as currently planned. King does not undertake to publicly update or revise any of its forward-looking statements even if experience or future changes show that the indicated results or events will not be realized.

A service of YellowBrix, Inc.